De novo development of Clinical Practice Guidelines or adaptation of high-quality international Guidelines. When and how

EUnetHTA Core Model. [Internet]. [cited 6 May 24]. Available at: https://www.eunethta.eu/wp-content/uploads/2018/01/HTACoreModel3.0.pdf

OCED. Health at a Glance; Main causes of Mortality. [Internet]. [cited 6 May 24]. Available at: https://www.oecd-ilibrary.org/sites/216c1c0e-en/index.html?itemId=/content/component/216c1c0e-en

Oseran AS, Ati S, Feldman WB, Gondi S, Yeh RW, Wadhera RK. Assessment of Prices for Cardiovascular Tests and Procedures at Top-Ranked US Hospitals. JAMA Intern Med. 2022;182(9):996-999. doi: 10.1001/jamainternmed.2022.2602

Santos M., Silveira da Silva A, Wekmuller França AC, da Silva Magliano CA , Meirelles I , Schroeder L, Piccin Padilla M, Safatle L. Informe completo regional de avaliação de tecnologias sobre os inibidores seletivos das quinases dependentes de ciclina no tratamento do câncer de mama luminal avançado/metastático, em mulheres pós menopáusicas sem história de resistência à hormonioterapia.

McIntosh SA, Alam F, Adams L, Boon IS, Callaghan J, Conti I, et al. Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments. Lancet Oncol. 2023;24(6):636-645. doi: 10.1016/S1470-2045(23)00182-1.

World health Organizations The top 10 causes of death. [Internet]. [cited 6 May 24]. Available at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death

World health Organizations Distribution of R&D funding flows for neglected diseases by country, funder, and recipient organizations. [Internet]. [cited 6 May 24]. Available at: https://www.who.int/observatories/global-observatory-on-health-research-and-development/monitoring/distribution-of-r-d-funding-flows-for-neglected-diseases-by-country-funder-recipient-organization